| 发明名称 |
Method for Treating a GD2 Positive Cancer |
| 摘要 |
Preparations and methods for treating a GD2 positive cancer by administering a preparation comprising an anti-GD2 antibody to a patient, wherein the patient is not concomitantly treated with Interleukin-2 (IL-2), and wherein one or more treatment periods with the antibody may be preceded, accompanied, and/or followed by one or more treatment periods with a retinoid. |
| 申请公布号 |
US2014170155(A1) |
申请公布日期 |
2014.06.19 |
| 申请号 |
US201414182776 |
申请日期 |
2014.02.18 |
| 申请人 |
APEIRON BIOLOGICS AG |
发明人 |
Loibner Hans;Mutschlechner Oliver;Ladenstein Ruth;Klier Isabel |
| 分类号 |
C07K16/28;A61K45/06;A61K31/485;A61K39/395 |
主分类号 |
C07K16/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating a GD2 positive cancer in a patient comprising administering an anti-GD2 antibody to the patient without concomitantly administering IL-2, wherein a GD2 positive cancer is treated in the patient.
|
| 地址 |
Vienna AT |
